Nitric oxide and the CABG patient

Current Opinion in Pharmacology

Volumn 12, Issue 2, 2012, Pages 195-202

  Suvorava, Tatsiana ^a   Dao, Vu Thao Vi ^a   Bas, Murat ^b   Kojda, Georg ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; LOOP DIURETIC AGENT; NEBIVOLOL; NICORANDIL; NITRATE; NITRIC OXIDE; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; QUINAPRIL; SILDENAFIL;

ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COUGHING; DIABETES MELLITUS; DRUG MECHANISM; EXERCISE; GRAFT FAILURE; HEART FAILURE; HUMAN; HYPERTENSION; HYPOTENSION; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; VASCULAR ENDOTHELIUM; VASCULAR PATENCY;

EID: 84861653554     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.01.004     Document Type: Review

References (86)

1. J.L. Anderson, C.D. Adams, E.M. Antman, C.R. Bridges, R.M. Califf, D.E. Casey Jr., W.E. Chavey, F.M. Fesmire, J.S. Hochman, and T.N. Levin ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 2007 e1 e157
2. P.W. Serruys, M.C. Morice, A.P. Kappetein, A. Colombo, D.R. Holmes, M.J. Mack, E. Stahle, T.E. Feldman, B.M. van den, and E.J. Bass Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
3. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
4. S. Moncada, and A. Higgs Mechanisms of disease: the l-arginine-nitric oxide pathway N Engl J Med 329 1993 2002 2012
5. L.J. Ignarro Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein Circ Res 65 1989 1 21
6. F. Murad Shattuck lecture. Nitric oxide and cyclic GMP in cell signaling and drug development N Engl J Med 355 2006 2003 2011
7. C.F. Mueller, K. Laude, J.S. McNally, and D.G. Harrison ATVB in focus: redox mechanisms in blood vessels Arterioscler Thromb Vasc Biol 25 2005 274 278
8. M.T. Gewaltig, and G. Kojda Vasoprotection by nitric oxide: mechanisms and therapeutic potential Cardiovasc Res 55 2002 250 260
9. J.S. Beckman, and W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am J Physiol 271 1996 C1424 C1437
10. B. Lima, M.T. Forrester, D.T. Hess, and J.S. Stamler S-nitrosylation in cardiovascular signaling Circ Res 106 2010 633 646
11. V. Schachinger, M.B. Britten, and A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
12. J.H. Alexander, G. Hafley, R.A. Harrington, E.D. Peterson, T.B. Ferguson Jr., T.J. Lorenz, A. Goyal, M. Gibson, M.J. Mack, and D. Gennevois Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial JAMA 294 2005 2446 2454
13. V.R. Conti, and G.C. Hunter Gene therapy and vein graft patency in coronary artery bypass graft surgery JAMA 294 2005 2495 2497
14. P. Parang, and R. Arora Coronary vein graft disease: pathogenesis and prevention Can J Cardiol 25 2009 e57 e62
15. G.M. FitzGibbon, H.P. Kafka, A.J. Leach, W.J. Keon, G.D. Hooper, and J.R. Burton Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J Am Coll Cardiol 28 1996 616 626
16. L. Campeau, M. Enjalbert, J. Lesperance, M.G. Bourassa, P. Kwiterovich Jr., S. Wacholder, and A. Sniderman The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery N Engl J Med 311 1984 1329 1332
17. B.W. Lytle Prolonging patency - choosing coronary bypass grafts N Engl J Med 351 2004 2262 2264
18. J.H. Shuhaiber, A.N. Evans, M.G. Massad, and A.S. Geha Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery Eur J Cardiothorac Surg 22 2002 387 396
19. T.F. Lüscher, D. Diedrich, R. Siebenmann, K. Lehmann, and P. Stülz Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts N Engl J Med 319 1988 462 467
20. R.A. Moggio, J.Z. Ding, C.J. Smith, R.R. Tota, M.B. Stemerman, and G.E. Reed Immediate-early gene expression in human saphenous veins harvested during coronary artery bypass graft operations J Thorac Cardiovasc Surg 110 1995 209 213
21. N.L. Mills Arterial grafts for coronary artery bypass Adv Card Surg 9 1997 195 216
22. A.L. Hawkes, M. Nowak, B. Bidstrup, and R. Speare Outcomes of coronary artery bypass graft surgery Vasc Health Risk Manag 2 2006 477 484
23. P. Achouh, R. Boutekadjirt, D. Toledano, N. Hammoudi, J.Y. Pagny, P. Goube, K.O. Isselmou, B. Lancelin, R. Fouquet, and C. Acar Long-term (5-20-year) patency of the radial artery for coronary bypass grafting J Thorac Cardiovasc Surg 140 2010 73 79
24. O.M. Shapira, A.M. Xu, G.S. Aldea, J.A. Vita, R.J. Shemin, and J.F. Keaney Jr. Enhanced nitric oxide-mediated vascular relaxation in radial artery compared with interval mammary artery or saphenous vein Circulation 100 1999 322 327
25. P.A. Hayward, I.R. Gordon, D.L. Hare, G. Matalanis, M.L. Horrigan, A. Rosalion, and B.F. Buxton Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: results from the Radial Artery Patency and Clinical Outcomes trial J Thorac Cardiovasc Surg 139 2010 60 65
26. M. Hata, I. Yoshitake, S. Wakui, S. Unosawa, H. Kimura, H. Hata, and M. Shiono Long-term patency rate for radial artery vs. saphenous vein grafts using same-patient materials Circ J 75 2011 1373 1377
27. P. Collins, C.M. Webb, C.F. Chong, and N.E. Moat Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up Circulation 117 2008 2859 2864
28. N.D. Desai, E.A. Cohen, C.D. Naylor, and S.E. Fremes A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts N Engl J Med 351 2004 2302 2309
29. U.N. Khot, D.T. Friedman, G. Pettersson, N.G. Smedira, J. Li, and S.G. Ellis Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts Circulation 109 2004 2086 2091
30. J.C. Tsui, D.S. Souza, D. Filbey, V. Bomfim, and M.R. Dashwood Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a 'no-touch' technique Br J Surg 88 2001 1209 1215
31. T.V. Bilfinger, and G.B. Stefano Human aortocoronary grafts and nitric oxide release: relationship to pulsatile pressure Ann Thorac Surg 69 2000 480 485
32. F. Viaro, V.K. Capellini, A.C. Celotto, C.G. Carlotti Jr., A.J. Rodrigues, G.S. Reis, V.S. Augusto, and P.R. Evora Immunohistochemical evaluation of three nitric oxide synthase isoforms in human saphenous vein exposed to different degrees of distension pressures Cardiovasc Pathol 19 2010 e211 e220
33. D. Souza A new no-touch preparation technique. Technical notes Scand J Thorac Cardiovasc Surg 30 1996 41 44
34. M.R. Dashwood, K. Savage, A. Dooley, X. Shi-Wen, D.J. Abraham, and D.S. Souza Effect of vein graft harvesting on endothelial nitric oxide synthase and nitric oxide production Ann Thorac Surg 80 2005 939 944
35. B.L. Johansson, D.S. Souza, L. Bodin, D. Filbey, and L. Bojo No touch vein harvesting technique for CABG improves the long-term clinical outcome Scand Cardiovasc J 43 2009 63 68
36. M. Wilbring, S.M. Tugtekin, B. Zatschler, A. Ebner, H. Reichenspurner, K. Matschke, and A. Deussen Even short-time storage in physiological saline solution impairs endothelial vascular function of saphenous vein grafts Eur J Cardiothorac Surg 40 2011 811 815
37. B. Zatschler, P. Dieterich, B. Muller, M. Kasper, U. Rauen, and A. Deussen Improved vessel preservation after 4 days of cold storage: experimental study in rat arteries J Vasc Surg 50 2009 397 406
38. T. Wille, H. de Groot, and U. Rauen Improvement of the cold storage of blood vessels with a vascular preservation solution. Study in porcine aortic segments J Vasc Surg 47 2008 422 431
39. E. Lanzarone, F. Gelmini, A. Fumero, M. Carini, M.L. Costantino, R. Fumero, and O. Alfieri Preservation of endothelium nitric oxide release during beating heart surgery with respect to continuous flow cardiopulmonary bypass Perfusion 25 2010 57 64
40. A. Gonenc, A. Hacisevki, H.R. Griffiths, M. Torun, B. Bakkaloglu, and B. Simsek Free radical reaction products and antioxidant capacity in beating heart coronary artery surgery compared to conventional bypass Biochemistry (Mosc) 76 2011 677 685
41. J. Huffmyer, and J. Raphael The current status of off-pump coronary bypass surgery Curr Opin Anaesthesiol 24 2011 64 69
42. J.D. Puskas, W.H. Williams, R. O'Donnell, R.E. Patterson, S.R. Sigman, A.S. Smith, K.T. Baio, P.D. Kilgo, and R.A. Guyton Off-pump and on-pump coronary artery bypass grafting are associated with similar graft patency, myocardial ischemia, and freedom from reintervention: long-term follow-up of a randomized trial Ann Thorac Surg 91 2011 1836 1842
43. Y. Sugimura, M. Toyama, M. Katoh, M. Kotani, Y. Kato, and K. Hisamoto Outcome of composite arterial Y-grafts in off-pump coronary artery bypass Asian Cardiovasc Thorac Ann 19 2011 119 122
44. G. Kojda, and R. Hambrecht Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67 2005 187 197
45. N. Lauer, T. Suvorava, U. Rüther, R. Jacob, A. Meyer, D.G. Harrison, and G. Kojda Critical involvement of hydrogen peroxide in exercise-induced upregulation of endothelial NO-synthase Cardiovasc Res 65 2005 254 262
46. M.E. Davis, H. Cai, L. McCann, T. Fukai, and D.G. Harrison Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training Am J Physiol Heart Circ Physiol 284 2003 H1449 H1453
47. M.E. Davis, I.M. Grumbach, T. Fukai, A. Cutchins, and D.G. Harrison Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding J Biol Chem 279 2004 163 168
48. D.J. Green, A. Maiorana, G. O'Driscoll, and R. Taylor Effect of exercise training on endothelium-derived nitric oxide function in humans J Physiol 561 2004 1 25
49. T. Fukai, M.R. Siegfried, M. Ushio-Fukai, Y. Cheng, G. Kojda, and D.G. Harrison Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training J Clin Invest 105 2000 1631 1639
50. L.R. Johnson, J.W. Rush, J.R. Turk, E.M. Price, and M.H. Laughlin Short-term exercise training increases ACh-induced relaxation and eNOS protein in porcine pulmonary arteries J Appl Physiol 90 2001 1102 1110
51. T. Miyauchi, S. Maeda, M. Iemitsu, T. Kobayashi, Y. Kumagai, I. Yamaguchi, and M. Matsuda Exercise causes a tissue-specific change of NO production in the kidney and lung J Appl Physiol 94 2003 60 68
52. T. Dao, M. Floeren, S. Kumpf, C. Both, B. Peter, V. Balz, T. Suvorava, and G. Kojda Catalase activity prevents exercise-induced upregulation of vasoprotective proteins in venous tissue J Cell Mol Med 2010 10.1111/j.1582-4934.2010.01227.x
53. K.A. Eagle, R.A. Guyton, R. Davidoff, F.H. Edwards, G.A. Ewy, T.J. Gardner, J.C. Hart, H.C. Herrmann, L.D. Hillis, and A.M. Hutter Jr. T.A. Orszulak ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) Circulation 110 2004 e340 e437
54. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, and J. Knuuti Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
55. S. Yusuf, E. Fallen, R.A. Harrington, and R.A. Guyton Clinical decisions. Management of stable coronary disease N Engl J Med 357 2007 1762 1766
56. W.E. Boden, R.A. O'Rourke, K.K. Teo, P.M. Hartigan, D.J. Maron, W.J. Kostuk, M. Knudtson, M. Dada, P. Casperson, and C.L. Harris Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
57. E.J. Velazquez, K.L. Lee, M.A. Deja, A. Jain, G. Sopko, A. Marchenko, I.S. Ali, G. Pohost, S. Gradinac, and W.T. Abraham Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 2011 1607 1616
58. U. Laufs, V. La Fata, J. Plutzky, and J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
59. I. Fleming Signaling by the angiotensin-converting enzyme Circ Res 98 2006 887 896
60. U.M. Steckelings, M. Larhed, A. Hallberg, R.E. Widdop, E.S. Jones, C. Wallinder, P. Namsolleck, B. Dahlof, and T. Unger Non-peptide AT2-receptor agonists Curr Opin Pharmacol 11 2011 187 192
61. M. Bas, V. Adams, T. Suvorava, T. Niehues, T.K. Hoffmann, and G. Kojda Non-allergic angioedema. Role of bradykinin Allergy 62 2007 842 856
62. A. Sasmazel, A. Baysal, A. Fedekar, F. Buyukbayrak, O. Bugra, H. Erdem, C. Aydin, A. Caliskan, and H. Sunar The effect of statin therapy on stimulation of endothelium-derived nitric oxide before and after coronary artery bypass surgery Heart Surg Forum 13 2010 E243 E246
63. C. Antoniades, C. Bakogiannis, P. Leeson, T.J. Guzik, M.H. Zhang, D. Tousoulis, A.S. Antonopoulos, M. Demosthenous, K. Marinou, and A. Hale Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling Circulation 124 2011 335 345
64. K.B. Filion, L. Pilote, E. Rahme, and M.J. Eisenberg Perioperative use of cardiac medical therapy among patients undergoing coronary artery bypass graft surgery: a systematic review Am Heart J 154 2007 407 414
65. J.L. Rouleau, W.J. Warnica, R. Baillot, P.J. Block, S. Chocron, D. Johnstone, M.G. Myers, C.D. Calciu, S. Dalle-Ave, and P. Martineau Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery Circulation 117 2008 24 31
66. G. Kojda Direct vasoprotection by aspirin: a significant bonus to antiplatelet activity? Cardiovasc Res 64 2004 192 194
67. D.T. Mangano Aspirin and mortality from coronary bypass surgery N Engl J Med 347 2002 1309 1317
68. S. Gupta, and H.M. Wright Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide Cardiovasc Ther 26 2008 189 202
69. S. Yucel, M. Bahcivan, M.K. Gol, B.H. Erenler, F. Kolbakir, and H.T. Keceligil Reduced intimal hyperplasia in rabbits via medical therapy after carotid venous bypass Tex Heart Inst J 36 2009 387 392
70. E. Fung, R.R. Fiscus, A.P. Yim, G.D. Angelini, and A.A. Arifi The potential use of type-5 phosphodiesterase inhibitors in coronary artery bypass graft surgery Chest 128 2005 3065 3073
71. F.W. Sellke, R.J. Tomanek, and D.G. Harrison l-Cysteine selectively potentiates nitroglycerin-induced dilation of small coronary microvessels J Pharmacol Exp Ther 258 1991 365 369
72. D. Martens, and G. Kojda Impaired vasodilator response to organic nitrates in isolated basilar arteries Br J Pharmacol 132 2001 30 36
73. Y. Paz, J. Gurevitch, I. Frolkis, I. Shapira, D. Pevni, A. Kramer, C. Locker, and R. Mohr Vasoactive response of different parts of human internal thoracic artery to isosorbide-dinitrate and nitroglycerin: an in vitro study Eur J Cardiothorac Surg 19 2001 254 259
74. D. Zabeeda, B. Medalion, S. Jackobshvilli, S. Ezra, A. Schachner, and A.J. Cohen Comparison of systemic vasodilators: effects on flow in internal mammary and radial arteries Ann Thorac Surg 71 2001 138 141
75. O.M. Shapira, J.D. Alkon, D.S. Macron, J.F. Keaney Jr., J.A. Vita, G.S. Aldea, and R.J. Shemin Nitroglycerin is preferable to diltiazem for prevention of coronary bypass conduit spasm Ann Thorac Surg 70 2000 883 888
76. J. Gurevitch, H.I. Miller, I. Shapira, A. Kramer, Y. Paz, M. Matsa, R. Mohr, and V. Yakirevich High-dose isosorbide dinitrate for myocardial revascularization with composite arterial grafts Ann Thorac Surg 63 1997 382 387
77. N. Roubos, F.L. Rosenfeldt, S.M. Richards, R.A. Conyers, and B.B. Davis Improved preservation of saphenous vein grafts by the use of glyceryl trinitrate-verapamil solution during harvesting Circulation 92 1995 II31 II36
78. I.S. Ali, K.J. Buth, and A. Maitland Impact of preoperative intravenous nitroglycerin on in-hospital outcomes after coronary artery bypass grafting for unstable angina Am Heart J 148 2004 727 732
79. A.L. Shroyer, M.E. Plomondon, F.L. Grover, and F.H. Edwards The 1996 coronary artery bypass risk model: the Society of Thoracic Surgeons Adult Cardiac National Database Ann Thorac Surg 67 1999 1205 1208
80. A. Hacker, S. Müller, W. Meyer, and G. Kojda The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis Br J Pharmacol 132 2001 1707 1714
81. S. Muller, I. Konig, W. Meyer, and G. Kojda Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate J Am Coll Cardiol 44 2004 624 631
82. K. Abbasi, K. Shalileh, M.S. Anvari, S. Rabbani, A. Mahdanian, S.H. Ahmadi, N. Moshtaghi, N. Movahedi, and A. Karimi Perivascular nitric oxide delivery to saphenous vein grafts prevents graft stenosis after coronary artery bypass grafting: a novel sheep model Cardiology 118 2011 8 15
83. T. Suvorava, and G. Kojda Nitric oxide delivering devices to prevent saphenous vein graft failure? Cardiology 118 2011 104 106
84. G. Kojda Role of nicorandil in ischaemic preconditioning Lancet 360 2002 1889
85. The IONA Study Group Effect of nicorandil on coronary events in patients with stable angina: the impact of nicorandil (IONA) randomised trial Lancet 359 2002 1269 1275
86. S. Yamamoto, T. Yamada, Y. Kotake, and J. Takeda Cardioprotective effects of nicorandil in patients undergoing on-pump coronary artery bypass surgery J Cardiothorac Vasc Anesth 22 2008 548 553